chevron_leftBack
As of 24 April 2025, Evolva Holding S.A. has a market cap of $9.6M USD, ranking #32869 globally and #225 in Switzerland. It ranks #3284 in the Healthcare sector, and #1090 in the Biotechnology industry.
Key Stats
Market Cap
$9.6MUSD
7.93M CHF
Enterprise Value
$1.42MUSD
1.18M CHF
EBITDA (TTM)
$4.46MUSD
3.7M CHF
Net Income (TTM)
$1.26MUSD
1.04M CHF
PE Ratio
7.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
Employees
78
Founded
2001
Website
evolva.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -6.8% | 4.8% | -2.7% | 25% | 8.9% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
EVE
Evolva Holding SA
ISIN: CH1262055788
Shares Out.:
Shares Outstanding:
7.212M1
Shares Float:
6.995M2
|
1.10 CHF | |
|
0QQJ
Evolva Holding SA
ISIN: CH1262055788
|
1.22 CHF | |
|
ELVAF
Evolva Holding SA
ISIN: CH1262055788
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.9000 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Evolva Holding S.A.
Evolva Holding SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was incorporated in 2001 and is headquartered in Reinach, Switzerland.
